ABBV/ENTA obvious pattern—Viekira market share is much higher in populations that are predominantly GT1b (EU, Japan) than in populations that are predominantly GT1a (US).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”